mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.02 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.03 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.04 |